568例肾上腺肿物临床回顾性分析
Clinical Retrospective Analysis of 568 Adren-al Mass
DOI: 10.12677/ACM.2023.1361427, PDF,    科研立项经费支持
作者: 耿茜茜, 火 睿*:石河子大学第一附属医院内分泌代谢科,新疆 石河子
关键词: 肾上腺肿物肾上腺意外瘤原发性醛固酮增多症库欣综合征嗜铬细胞瘤Adrenal Mass Adrenal Incidentaloma Primary Aldosteronism Cushing’s Syndrome Pheochromocytoma
摘要: 目的:分析肾上腺肿物疾病谱的变化趋势及临床特点,尤其是肾上腺意外瘤(Adrenal Incidentaloma, AI)的病因构成及临床特点。方法:回顾性分析2012年1月至2022年12月于石河子大学第一附属医院经手术病理证实的肾上腺肿物患者568例的病例资料,包括性别、年龄、既往史、就诊原因、临床症状、实验室指标、影像学资料、术后病理及免疫组化等。结果:1) 568例肾上腺肿物患者中,465例完善了内分泌功能评估,按有无功能进行分组,功能性肿瘤中原发性醛固酮增多症(primary aldosteronism, PA)居于首位(53.9%),无功能性肿瘤中的无功能腺瘤占比最高(69.8%);2) 与无功能瘤组相比,功能性肿瘤组BMI、肿瘤大小、SBP、DBP、血钠、平扫及增强期CT值偏高(均P < 0.05),而年龄、血钾、GFR偏低(均P < 0.05)。3) 568例肾上腺肿物中共发现243例AI患者,其中188例完善激素评估,居于首位的是无功能瘤(38.3%),其次为PA (25.5%);4) 188例AI按是否合并高血压进行分组,合并高血压组年龄、BMI、嗜铬细胞瘤(pheochromocytoma, PCC)、库欣综合征(Cushing’s syndrome, CUS)、PA均高于血压正常组(均P < 0.05),而血钾、GFR低于血压正常组(均P < 0.05)。结论:肾上腺肿物检出率逐渐增加,其中近半数患者为AI患者,临床医生加强对疾病认识的同时,应规范其诊疗流程,避免功能性肿瘤的漏诊和误诊。
Abstract: Objective: To analyze the disease spectrum trend and clinical characteristics of adrenal mass, espe-cially the etiology and clinical characteristics of AI. Methods: Retrospective analysis of the case data of 568 patients with adrenal masses confirmed by surgery and pathology in the First Affiliated Hos-pital of Shihezi University from January 2012 to December 2022, including gender, age, past history, medical reasons, clinical symptoms, laboratory indicators, imaging data, postoperative pathology and immunohistochemistry. Results: 1) Among the 568 patients with adrenal mass, 465 improved the endocrine function assessment and grouped according to the presence of function. Among func-tional tumors, PA was the first (53.9%), and the proportion of non-functional adenomas was the highest (69.8%). 2) Compared with the nonfunctional tumor group, BMI, tumor size, SBP, DBP, blood sodium, plain scan, and enhanced CT values were higher (all P < 0.05), while age, blood potas-sium, and GFR were lower (all P < 0.05). 3) A total of 243 AI patients were found in 568 adrenal masses, of which 188 patients were nonfunctional tumors (38.3%), followed by PA (25.5%); 4) 188 AI cases were grouped by hypertension, with hypertension, age, BMI, Pheochromocytoma (PCC), Cushing’s syndrome (CUS) and PA were higher than the normotensive group (all P < 0.05), while serum potassium and GFR were lower than the normotensive group (both P < 0.05). Conclusion: The detection rate of adrenal mass is gradually increasing, and nearly half of the patients are AI patients. While clinicians strengthen their understanding of the disease, they should standardize their diag-nosis and treatment procedures to avoid the missed diagnosis and misdiagnosis of functional tu-mors.
文章引用:耿茜茜, 火睿. 568例肾上腺肿物临床回顾性分析[J]. 临床医学进展, 2023, 13(6): 10194-10201. https://doi.org/10.12677/ACM.2023.1361427

参考文献

[1] 李乐乐, 窦京涛, 谷伟军, 等. 4049例肾上腺病变患者回顾性临床分析[J]. 中华医学杂志, 2014, 94(42): 3314-3318.
[2] Fassnacht, M., Arlt, W., Bancos, I., et al. (2016) Management of Adrenal Incidentalomas: European Society of Endocrinology Clinical Practice Guideline in Collaboration with the European Network for the Study of Ad-renal Tumors. European Journal of Endocrinology, 175, G1-G34. [Google Scholar] [CrossRef
[3] 田成功. 肾上腺意外瘤[M]//陈家伦. 临床内分泌学. 上海: 上海科学技术出版社, 2011: 597-601.
[4] Kastelan, D., Kraljevic, I., Dusek, T., et al. (2015) The Clinical Course of Patients with Adrenal Incidentaloma: Is It Time to Reconsid-er the Current Recommendations? European Journal of Endocrinology, 173, 275-282. [Google Scholar] [CrossRef
[5] Funder, J.W., Carey, R.M., Mantero, F., et al. (2016) The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 101, 1889-1916. [Google Scholar] [CrossRef] [PubMed]
[6] Nieman, L.K. (2015) Update on Subclinical Cushing’s Syndrome. Cur-rent Opinion in Endocrinology, Diabetes and Obesity, 22, 180-184. [Google Scholar] [CrossRef
[7] Guaraldi, F. and Salvatori, R. (2012) Cushing Syndrome: Maybe Not So Uncommon of an Endocrine Disease. Journal of the American Board of Family Medicine, 25, 199-208. [Google Scholar] [CrossRef] [PubMed]
[8] Lenders, J.W., Duh, Q.Y., Eisenhofer, G., et al. (2014) Pheo-chromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocri-nology & Metabolism, 99, 1915-1942. [Google Scholar] [CrossRef] [PubMed]
[9] 谭惠文, 唐宇, 余叶蓉, 等. 国际垂体协会《库欣病的诊断和管理共识(更新版)》解读——诊断篇[J]. 中国全科医学, 2022, 25(20): 2435-2442.
[10] Lafont, M., Fagour, C., Haissa-guerre, M., et al. (2015) Per-Operative Hemodynamic Instability in Normotensive Patients with Incidentally Discovered Pheochromocytomas. The Journal of Clinical Endocrinology & Metabolism, 100, 417-421. [Google Scholar] [CrossRef] [PubMed]
[11] Dinnes, J., Bancos, I., Ferrante Di Ruffano, L., et al. (2016) Manage-ment of Endocrine Disease: Imaging for the Diagnosis of Malignancy in Incidentally Discovered Adrenal Masses: A Systematic Review and Meta-Analysis. European Journal of Endocrinology, 175, R51-R64. [Google Scholar] [CrossRef
[12] 肾上腺意外瘤多学科管理专家组. 肾上腺意外瘤多学科管理专家共识[J]. 中华内分泌外科杂志, 2021, 15(4): 325-336.
[13] Grossman, A., Koren, R., Tirosh, A., et al. (2016) Preva-lence and Clinical Characteristics of Adrenal Incidentalomas in Potential Kidney Donors. Endocrine Research, 41, 98-102. [Google Scholar] [CrossRef] [PubMed]
[14] Kloos, R.T., Gross, M.D., Francis, I.R., et al. (1995) Inci-dentally Discovered Adrenal Masses. Endocrine Research, 16, 460-484. [Google Scholar] [CrossRef] [PubMed]
[15] 李乐乐, 窦京涛, 谷伟军, 等. 1173例肾上腺意外瘤病因构成分析[J]. 中华医学杂志, 2014, 94(8): 587-590.
[16] Mantero, F., Terzolo, M., Arnaldi, G., et al. (2000) A Survey on Adrenal Incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. The Journal of Clinical Endocrinology & Metabolism, 85, 637-644. [Google Scholar] [CrossRef] [PubMed]